Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Warts 1Neoplasms 1

Interventions

Specimen Handling 76Bevacizumab 66Drug Therapy 64Cisplatin 64Carboplatin 63Magnetic Resonance Spectroscopy 59Radiotherapy 57pembrolizumab 54Gemcitabine 54Cyclophosphamide 54Capecitabine 51Oxaliplatin 50toripalimab 44Paclitaxel 41tislelizumab 40Standard of Care 39fludarabine 36Fluorouracil 35Injections 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Surgical Procedures, Operative 28Nivolumab 28Irinotecan 27Docetaxel 27Dexamethasone 27Leucovorin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Ivermectin × 1 year × Clear all
NCT07487805 2026-03-23

ICONIC

University of Florida

Phase 2 Not yet recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT07396714 2026-02-09

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Assiut University

Phase EARLY_PHASE1 Not yet recruiting
88 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡